You are not currently logged in.
Access JSTOR through your library or other institution:
Reduction in Incidence of Nosocomial Methicillin‐Resistant Staphylococcus aureus (MRSA) Infection in an Intensive Care Unit: Role of Treatment With Mupirocin Ointment and Chlorhexidine Baths for Nasal Carriers of MRSA
Ana Maria Sandri , MD, Micheline Gisele Dalarosa , MD, Luciana Ruschel de Alcântara , MD, Laura da Silva Elias , MD and Alexandre Prehn Zavascki , MD, PhD
Infection Control and Hospital Epidemiology
Vol. 27, No. 2 (February 2006), pp. 185-187
Published by: Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Stable URL: http://www.jstor.org/stable/10.1086/500625
Page Count: 3
Preview not available
After the introduction of routine treatment for every nasal carrier of methicillin‐resistant Staphylococcus aureus, active follow‐up surveillance for nosocomial methicillin‐resistant S. aureus infection was conducted for 5 years in an intensive care unit of a tertiary‐care teaching hospital. There was a significant decrease in the incidence of nosocomial methicillin‐resistant S. aureus infection during the later years of follow‐up. Decolonization of nasal carriers of methicillin‐resistant S. aureus is probably associated with such findings.
© 2006 by The Society for Healthcare Epidemiology of America. All rights reserved.